Found 98 matching trials
Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL) PHASE2 This is a phase ll study of participants with untreated diffuse large B Cel...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP PHASE2 In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Show More Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Learn More & Join Trial
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure PHASE2 This study evaluates a personalized treatment strategy for patients with la...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Learn More & Join Trial
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL PHASE2 This is a prospective, open-label, multicenter, randomized controlled study...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma PHASE1 The purpose of the study is to evaluate glofitamab + gemcitabine + oxalipla...
Show More Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors PHASE2 The aim of this study is to evaluate the efficacy and safety of CAR T-cell ...
Show More Location
Shanghai Ruijin Hospital
Learn More & Join Trial
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma PHASE2 The goal of this clinical trial is to see if a new combination of standard ...
Show More Location
Townsville University Hospital
Learn More & Join Trial
CAR-T Followed by Bispecific Antibodies PHASE2 The research study is being conducted to test the safety and effectiveness ...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma N/A This study aims to investigate the predictive value of PET imaging targetin...
Show More Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School
Learn More & Join Trial